Cardeas Pharma Obtains $5,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8e14fea4-bd41-4899-be4c-786be0d56406&Preview=1 -
Date
12/20/2011 -
Company Name
Cardeas Pharma -
Mailing Address
2518 Eastlake Ave. E. Seattle, WA 98102 -
Company Description
The company is a stealth mode pharmaceutical developer. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$5,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The company plans to use the money to run both preclinical experiments and initial clinical trials of a novel therapeutic to be used in hospitals. -
M&A Terms
-
Venture Investor
De Novo Ventures -
Venture Investor
Avalon Ventures -
Venture Investor
WRF Capital -
Venture Investor
Devon Park Bioventures
Pingback: Avalon Ventures, Coming Off Zynga Investment, Raising 10th Fund | Xconomy